Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis.

Deltenre, Pierre;Trépo, Eric;Fujiwara, Naoto;Goossens, Nicolas;Hoshida, Yujin;et.al.
(2020) Liver International — Vol. 40, n° 3, p. 565-570 (2020)

Files

DeltenrePLiverInt2019.pdf
  • Open Access
  • Adobe PDF
  • 516.75 KB

Details

Authors
  • Deltenre, Pierreorcid-logo
    Author
  • Trépo, Eric
    Author
  • Fujiwara, Naoto
    Author
  • Goossens, Nicolas
    Author
  • Marot, Astridorcid-logoUCLouvain
    Author
  • Hoshida, Yujin
    Author
Show more
Abstract
(en) BACKGROUND: The gene-signature-model for end stage liver disease (gs-MELD) score has been shown to be a strong predictor of 6-month survival in severe alcoholic hepatitis (AH). Currently, only a few studies have evaluated the long-term prognosis of patients with severe AH. AIM: To assess the prognostic value of the gs-MELD score at 5 years in patients with severe AH. METHODS: Forty-eight consecutive patients with AH (25 males, median age 52 years [95% IC: 48-56]) were included. RESULTS: The median gs-MELD score was 2.6 (95% CI: 2.2-3.0). According to the gs-MELD score, 22 patients (46%) were considered to have a poor prognosis. During a median follow-up of 29 months (95% CI: 4-43), 19 patients (40%) were abstinent and 24 patients (50%) died. At 5 years, rates of survival were 61% (95% CI: 41-81) and 26% (95% CI: 11-55) in patients with low and high gs-MELD scores (P = .001), and 81% (95% CI: 58-96) and 22% (95% CI: 10-47) in abstainers and in consumers (P < .001) respectively. In multivariable competing risk regression modelling, gs-MELD score (subdistribution hazard ratio: 5.78, 95% CI: 2.17-15.38, P < .001) and recurrent alcohol consumption (subdistribution hazard ratio: 12.18, 95% CI: 3.16-46.95, P < .001) were independently associated with 5-year mortality. CONCLUSIONS: Both gs-MELD score and alcohol consumption drive AH long-term prognosis. The gs-MELD score may guide the development of molecularly targeted therapies in AH.
Affiliations

Citations

Deltenre, P., Trépo, E., Fujiwara, N., Goossens, N., Marot, A., Dubois, M., Spahr, L., Henrion, J., Moreno, C., & Hoshida, Y. (2020). Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis. Liver International, 40(3), 565-570. https://doi.org/10.1111/liv.14265 (Original work published 2020)